应用和采用人工智能用于药物发现的数据中心挑战
Ghita Ghislat1, Saiveth Hernandez-Hernandez2, Chayanit Piyawajanusorn3
1Department of Life Sciences, Imperial College London, London, UK.
Expert opinion on drug discovery
|September 24, 2024
概括
药物发现中的人工智能 (AI) 面临着数据问题,错误的评估和人类偏见的挑战. 解决这些问题对于实现AI在开发新药的潜力至关重要.
科学领域:
- 药物的发现和开发.
- 人工智能应用的人工智能应用.
- 计算化学是一种计算化学.
背景情况:
- 人工智能 (AI) 为加速药物发现和降低相关成本提供了巨大的潜力.
- 当前的人工智能模型面临的局限性影响了它们在现实世界药物开发中的范围和有效性.
研究的目的:
- 确定和讨论阻碍人工智能在药物发现中的影响的关键挑战.
- 探索有效的缓解数据问题,不确定性量化和评估陷.
- 突出人类偏见的作用和前性验证的重要性.
主要方法:
- 审查和讨论用于药物发现的AI中常见的数据问题 (例如偏差,小尺寸,高维度).
- 对AI模型预测不确定性量化的挑战分析.
- 在AI模型评估中检查概念错误,基准和性能误估.
- 讨论人类偏见和未来经验的需要.
主要成果:
- 数据的局限性,如偏差,不一致性和高维度,对AI模型性能构成重大挑战.
- 不确定性量化技术在提高人工智能预测的信任和可靠性方面遇到了障碍.
- 错误的评估方法,包括不切实际的基准和绩效错误估计,可能会阻碍人工智能模型的开发.
- 专家对人类的偏见可能会对人工智能开发和应用产生负面影响.
结论:
- 克服数据挑战,改善不确定性量化和完善评估策略对于推动药物发现中的AI至关重要.
- 未来的验证和对人类偏见的认识对于实现人工智能模型的实际价值至关重要.
- 需要编辑,资助者,投资者和研究人员做出明智的决定,以指导对药物发现人工智能的负责任开发.
更多相关视频
相关概念视频
Drug Discovery: Overview
7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K
Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Drug Administration and Therapy Phases: Overview
416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
Drug Control Governance: Regulatory Bodies and Their Impact
145
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
145


